S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations|
|Charles River Laboratories to Present at J.P. Morgan Healthcare Conference|
|Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA|
|POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA|
|Bristol-Myers Squibb Receives Complete Response Letter from U.S. Food and Drug Administration for Daclatasvir, an Investigational Treatment for Hepatitis C|
|AcelRx Pharmaceuticals Reports Third Quarter 2014 Financial Results|
|SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. - POZN (2014/12/17)|
|AcelRx Pharmaceuticals Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting|
|AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso|
|Akorn Reports Preliminary 2014 Third Quarter Results|
Click above to view more mutual fund data and stats for crl - Charles River Laboratories International Inc.